DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

PEG-Intron (Peginterferon Alfa-2B) - Pneumonia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Pneumonia ()

Below is the selection of side effect reports (a.k.a. adverse event reports) related to PEG-Intron (Peginterferon Alfa-2B) where reactions include pneumonia. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of    Next >>

Possible PEG-Intron side effects in

Reported by a physician from United States on 2012-08-27

Patient:

Reactions: Product Quality Issue, Abdominal Discomfort, Malaise, Pneumonia, Nasopharyngitis, Vomiting, Bronchitis, Cough

Drug(s) suspected as cause:
PEG-Intron

Other drugs received by patient: Lisinopril; Seroquel



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-23

Patient:

Reactions: Pneumonia, Platelet Count Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram
    Start date: 2012-03-06
    End date: 2012-03-13

PEG-Intron
    Dosage: 0.75 microgram per kilogram, qw
    Start date: 2012-05-15

PEG-Intron
    Dosage: 0.75 microgram per kilogram, qw
    Start date: 2012-03-20
    End date: 2012-05-01

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Start date: 2012-05-15

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-06
    End date: 2012-05-07

Telaprevir
    Dosage: 2250 mg, qd
    Administration route: Oral
    Start date: 2012-05-15
    End date: 2012-06-05

Telaprevir
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-06
    End date: 2012-05-07

Other drugs received by patient: Betamethasone Sodium Phosphate; [therapy Unspecified]; Allegra; Allopurinol; Rabeprazole Sodium; Atarax; Meropenem



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-23

Patient:

Reactions: Weight Decreased, Pneumonia, Pruritus, Dyspnoea, Nausea, Pain, Haemoglobin Abnormal, Irritability, Diplopia, Fatigue, Lung Disorder, Dizziness, Asthenia, Decreased Appetite, Influenza

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-02-07

Rebetol
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-02-07

Telaprevir
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-02-07

Other drugs received by patient: Morphine; Synthroid; Oxycodone HCL; Nexium



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-13

Patient:

Reactions: Pneumonia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-05-15
    End date: 2012-07-03

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-15
    End date: 2012-05-28

Rebetol
    Administration route: Oral
    Start date: 2012-05-29
    End date: 2012-06-04

Rebetol
    Administration route: Oral
    Start date: 2012-06-05
    End date: 2012-07-03

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-15
    End date: 2012-07-03



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-31

Patient:

Reactions: Pneumonia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1 df, qw
    Indication: Hepatitis C

Rebetol

Victrelis



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-27

Patient:

Reactions: Weight Decreased, Pneumonia, Nausea, Musculoskeletal Discomfort, Headache, Pyrexia, Eating Disorder, Dysgeusia, Diarrhoea, Skin Odour Abnormal, Heart Rate Increased, Chest Pain

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-04-29

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-04-29

Victrelis
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-05-27



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-18

Patient:

Reactions: Pneumonia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1 df, qw
    Indication: Hepatitis C

Rebetol

Victrelis



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from United States on 2012-07-17

Patient:

Reactions: Pneumonia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1 df, qw
    Indication: Hepatitis C

Rebetol

Victrelis



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from United States on 2012-07-11

Patient:

Reactions: Abdominal Discomfort, Malaise, Pneumonia, Nasopharyngitis, Vomiting, Bronchitis, Cough

Drug(s) suspected as cause:
PEG-Intron

Other drugs received by patient: Lisinopril; Seroquel



Possible PEG-Intron side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-27

Patient: male

Reactions: Haemorrhoid Operation, Pneumonia, Pain, Pulmonary Thrombosis, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Indication: Hepatitis C
    Start date: 2012-03-09

Ribavirin
    Indication: Hepatitis C
    Start date: 2012-03-09

Victrelis
    Indication: Hepatitis C
    Start date: 2012-04-13



Possible PEG-Intron side effects in 43 year old male

Reported by a physician from Portugal on 2012-06-19

Patient: 43 year old male

Reactions: Pneumonia, Anaemia, Drug Dependence, Septic Shock, Leukopenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Heroin (Diamorphine)
    Indication: Product Used FOR Unknown Indication

PEG-Intron
    Indication: Product Used FOR Unknown Indication

Rebetol
    Indication: Product Used FOR Unknown Indication

Victrelis
    Indication: Product Used FOR Unknown Indication



Possible PEG-Intron side effects in 70 year old female

Reported by a physician from United States on 2012-06-12

Patient: 70 year old female

Reactions: Renal Failure, Pneumonia, Respiratory Failure, Anaemia, Bacterial Infection, Septic Shock

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 150 mcg;qw;po
    Administration route: Oral
    Indication: Hepatitis C

Ribavirin
    Dosage: 600 mg;bid;po
    Administration route: Oral
    Indication: Hepatitis C

Victrelis
    Dosage: 800 mg;tid;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-11-03

Victrelis
    Dosage: 800 mg;tid;po
    Administration route: Oral
    Indication: Hepatic Cirrhosis
    Start date: 2011-11-03



Possible PEG-Intron side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-08

Patient: female

Reactions: Weight Decreased, Pneumonia, Hepatitis C, Abasia, Fall, Tremor, Concussion, Disease Recurrence, Facial Bones Fracture

Drug(s) suspected as cause:
PEG-Intron
    Indication: Hepatitis C
    Start date: 2003-01-01
    End date: 2003-07-01

PEG-Intron
    Indication: Hepatitis C
    Start date: 2012-02-14

Ribavirin
    Indication: Hepatitis C
    Start date: 2012-02-14

Ribavirin
    Indication: Hepatitis C
    Start date: 2003-01-01
    End date: 2003-07-01



Possible PEG-Intron side effects in female

Reported by a physician from United States on 2012-04-27

Patient: female

Reactions: Pneumonia

Adverse event resulted in: death

Drug(s) suspected as cause:
PEG-Intron
    Indication: Hepatitis C

Ribavirin
    Indication: Hepatitis C

Victrelis
    Indication: Hepatitis C



Possible PEG-Intron side effects in 52 year old male

Reported by a consumer/non-health professional from Canada on 2012-04-20

Patient: 52 year old male

Reactions: Anxiety, Thrombosis, Dyspnoea, Pneumonia, Asthenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron

Other drugs received by patient: Heptovir



Possible PEG-Intron side effects in 57 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-05

Patient: 57 year old female

Reactions: Pneumonia, Staphylococcal Infection, Lung Infection, Escherichia Infection, Candidiasis

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
PEG-Intron
    Dosage: qw
    Indication: Hepatitis C
    Start date: 2011-07-01

Ribavirin
    Dosage: qd, po
    Administration route: Oral
    Indication: Hepatitis C

Victrelis
    Dosage: qd, po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-01

Victrelis
    Dosage: qd, po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-08-01
    End date: 2012-01-01



Possible PEG-Intron side effects in 57 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-02

Patient: 57 year old female

Reactions: Pneumonia, Staphylococcal Infection, Escherichia Infection, Candidiasis

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
PEG-Intron
    Dosage: ;qw;
    Indication: Hepatitis C
    Start date: 2011-07-01

Ribavirin
    Dosage: ;qd;po
    Administration route: Oral
    Indication: Hepatitis C

Victrelis
    Dosage: ;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-01

Victrelis
    Dosage: ;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-08-01
    End date: 2012-01-01



Possible PEG-Intron side effects in 64 year old male

Reported by a physician from Spain on 2012-03-23

Patient: 64 year old male, weighing 63.0 kg (138.6 pounds)

Reactions: Pneumonia, Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 100 mcg;qw;sc
    Indication: Hepatitis C
    Start date: 2012-01-13

Ribavirin
    Dosage: 800 mg;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-13

Victrelis
    Dosage: 800 mg;q8h;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-10

Other drugs received by patient: Propranolol; Amiloride Hydrochloride



Possible PEG-Intron side effects in 52 year old male

Reported by a consumer/non-health professional from Canada on 2012-03-20

Patient: 52 year old male

Reactions: Thrombosis, Anxiety, Pneumonia, Headache, Asthenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron



Possible PEG-Intron side effects in 57 year old female

Reported by a health professional (non-physician/pharmacist) from Australia on 2012-03-12

Patient: 57 year old female

Reactions: Pneumonia, Metabolic Acidosis, Necrosis, Hepatic Failure, Multi-Organ Failure, Renal Failure, Dialysis, Abscess, Pneumonia Staphylococcal, Septic Shock

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Boceprevir (Sch-503034)
    Dosage: 800 mg;tid
    Indication: Hepatitis C
    Start date: 2011-01-19
    End date: 2012-01-30

PEG-Intron
    Dosage: 100 mcg;qw;sc
    Indication: Hepatitis C
    Start date: 2011-01-19
    End date: 2012-01-30

Ribavirin
    Dosage: 400mg;bid;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-01-19
    End date: 2012-01-30



Possible PEG-Intron side effects in 55 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-28

Patient: 55 year old male

Reactions: Pneumonia, Vomiting, RED Blood Cell Count Decreased, Impaired Healing, Haemoptysis, Alopecia, Blood Count Abnormal, Headache

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Indication: Hepatitis C
    Start date: 2011-12-14
    End date: 2012-02-03

PEG-Intron
    Indication: Hepatitis C
    Start date: 2009-12-30
    End date: 2010-04-26

Procrit
    Indication: Product Used FOR Unknown Indication

Rebetol
    Indication: Hepatitis C
    Start date: 2009-12-30
    End date: 2010-04-26

Rebetol
    Indication: Hepatitis C
    Start date: 2011-12-15
    End date: 2012-02-03

Victrelis
    Indication: Hepatitis C
    Start date: 2012-01-12
    End date: 2012-02-03



Possible PEG-Intron side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-21

Patient: female

Reactions: Pneumonia, Head Injury, Hypotension, Urinary Tract Infection, Abnormal Behaviour, Fall, Idiopathic Pulmonary Fibrosis, Mental Impairment, Insomnia, Feeling Abnormal

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Indication: Hepatitis C
    Start date: 2011-08-26
    End date: 2011-12-24

Ribavirin
    Indication: Hepatitis C
    Start date: 2011-08-26
    End date: 2011-12-24



Possible PEG-Intron side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-15

Patient: female

Reactions: White Blood Cell Count Decreased, Pneumonia, Chest Discomfort, Pulmonary Sarcoidosis, Incorrect Dose Administered, Biopsy Larynx Abnormal, Pyrexia, Staphylococcal Infection, Mental Disorder, Memory Impairment

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Indication: Hepatitis C
    Start date: 2012-01-09

PEG-Intron
    Indication: Hepatitis C
    Start date: 2011-01-07
    End date: 2011-08-15

Ribavirin
    Indication: Hepatitis C
    Start date: 2012-01-09

Ribavirin
    Indication: Hepatitis C
    Start date: 2011-01-07
    End date: 2011-08-15

Telaprevir
    Indication: Hepatitis C
    Start date: 2012-01-09



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-13

Patient:

Reactions: Hepatic Encephalopathy, Pneumonia, Sepsis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Indication: Hepatitis C

Victrelis
    Indication: Hepatitis C



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-09

Patient:

Reactions: Pneumonia, Hepatic Encephalopathy, Sepsis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Indication: Hepatitis C

Victrelis
    Indication: Hepatitis C



Possible PEG-Intron side effects in 26 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-01

Patient: 26 year old male, weighing 69.9 kg (153.7 pounds)

Reactions: Pneumonia, Respiratory Failure, Respiratory Arrest, Infection

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
PEG-Intron

Other drugs received by patient: Humira; Fosamax; Atenolol; Adderall 5; Entocort EC; Luvox



Possible PEG-Intron side effects in 61 year old male

Reported by a physician from Hungary on 2012-01-31

Patient: 61 year old male

Reactions: Haemoglobin Decreased, Agranulocytosis, Pneumonia, Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 150 mcg;qw;sc
    Indication: Hepatitis C
    Start date: 2011-09-30

Rebetol
    Dosage: 1200 mg;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-09-30

Victrelis
    Dosage: 2400 mg;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-09-30



Possible PEG-Intron side effects in female

Reported by a individual with unspecified qualification from United States on 2012-01-26

Patient: female

Reactions: Pneumonia, Staphylococcal Infection, Sarcoidosis, Pharyngitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Indication: Hepatitis C
    Start date: 2011-01-07
    End date: 2011-08-15

Ribavirin
    Indication: Hepatitis C
    Start date: 2011-01-07
    End date: 2011-08-15



Possible PEG-Intron side effects in 26 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-13

Patient: 26 year old male

Reactions: Pneumonia, Respiratory Failure

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Fosamax
    Administration route: Oral
    End date: 2011-10-06

PEG-Intron
    Indication: Hepatitis C
    Start date: 2011-07-22
    End date: 2011-10-06

Other drugs received by patient: Atenolol; Luvox; Entocort EC; Humira; Adderall Tablets; Vitamins (Unspecified)



Possible PEG-Intron side effects in 26 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-05

Patient: 26 year old male

Reactions: Pneumonia, Respiratory Failure

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Fosamax
    Administration route: Oral
    End date: 2011-10-06

PEG-Intron
    Indication: Hepatitis C
    Start date: 2011-07-22
    End date: 2011-10-06

Other drugs received by patient: Adderall Tablets; Luvox; Entocort EC; Vitamins (Unspecified); Humira; Atenolol



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012